Douglas F. Easton

Papers

Total Citations

H-Index

About

Douglas F. Easton is a preeminent cancer geneticist whose pioneering work has fundamentally shaped our understanding of inherited susceptibility to common cancers. His research centers on the identification and characterization of genetic variants that predispose individuals to breast, ovarian, and prostate cancers. Easton is best known for his leadership in large-scale genome-wide association studies (GWAS), which have uncovered dozens of risk loci for these diseases. His landmark contributions include the discovery of high-penetrance genes such as BRCA1 and BRCA2, as well as the elucidation of polygenic risk scores that now inform clinical risk prediction. With over 25 citations on his early work on prostate cancer genetics, his broader body of research has accumulated hundreds of thousands of citations, reflecting its profound impact on both basic science and clinical practice. Easton’s achievements include leading the Breast Cancer Association Consortium (BCAC) and the Collaborative Oncological Gene-Environment Study (COGS), which have transformed cancer prevention strategies. His work has been recognized with numerous awards, including the AACR Award for Lifetime Achievement in Cancer Research. For students and researchers, Easton exemplifies how rigorous genetic epidemiology can translate into tangible tools for personalized medicine.